REPORT ID 2542

Global Metabolic Disorders Drugs Market Research Report 2017

Publish Date
11-Dec-17
Pages
115
Format
Electronic (PDF)

In this report, the global Metabolic Disorders Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Metabolic Disorders Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Metabolic Disorders Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Zealand Pharma
    Rhythm
    OxThera
    Biophytis
    Biophytis
    Zafgen
    PerkinElmer
    Eternygen
    Pronutria Biosciences
    MedGenome
    CellCentric
    Nimbus Therapeutics
    Mitobridge
    Exelixis, Inc.
    Outpost Medicine
    Anchor Therapeutics
    Verva Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Tablet
    Injection
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Diabetes
    Disorders of the Thyroid and Pituitary Gland
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Metabolic Disorders Drugs Market Research Report 2017
1 Metabolic Disorders Drugs Market Overview
    1.1 Product Overview and Scope of Metabolic Disorders Drugs
    1.2 Metabolic Disorders Drugs Segment by Type (Product Category)
        1.2.1 Global Metabolic Disorders Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Metabolic Disorders Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Tablet
        1.2.4 Injection
    1.3 Global Metabolic Disorders Drugs Segment by Application
        1.3.1 Metabolic Disorders Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Diabetes
        1.3.3 Disorders of the Thyroid and Pituitary Gland
        1.3.4 Other
    1.4 Global Metabolic Disorders Drugs Market by Region (2012-2022)
        1.4.1 Global Metabolic Disorders Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Metabolic Disorders Drugs (2012-2022)
        1.5.1 Global Metabolic Disorders Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Metabolic Disorders Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Metabolic Disorders Drugs Market Competition by Manufacturers
    2.1 Global Metabolic Disorders Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Metabolic Disorders Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Metabolic Disorders Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Metabolic Disorders Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Metabolic Disorders Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Metabolic Disorders Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Metabolic Disorders Drugs Market Competitive Situation and Trends
        2.5.1 Metabolic Disorders Drugs Market Concentration Rate
        2.5.2 Metabolic Disorders Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Metabolic Disorders Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Metabolic Disorders Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Metabolic Disorders Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Metabolic Disorders Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Metabolic Disorders Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Metabolic Disorders Drugs Consumption by Region (2012-2017)
    4.2 North America Metabolic Disorders Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Metabolic Disorders Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Metabolic Disorders Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Metabolic Disorders Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Metabolic Disorders Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Metabolic Disorders Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Metabolic Disorders Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Metabolic Disorders Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Metabolic Disorders Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Metabolic Disorders Drugs Price by Type (2012-2017)
    5.4 Global Metabolic Disorders Drugs Production Growth by Type (2012-2017)

6 Global Metabolic Disorders Drugs Market Analysis by Application
    6.1 Global Metabolic Disorders Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Metabolic Disorders Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Metabolic Disorders Drugs Manufacturers Profiles/Analysis
    7.1 Zealand Pharma
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Zealand Pharma Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Rhythm
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Rhythm Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 OxThera
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 OxThera Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Biophytis
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Biophytis Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Biophytis
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Biophytis Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Zafgen
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Zafgen Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 PerkinElmer
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 PerkinElmer Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Eternygen
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Eternygen Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Pronutria Biosciences
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Pronutria Biosciences Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 MedGenome
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Metabolic Disorders Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 MedGenome Metabolic Disorders Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 CellCentric
    7.12 Nimbus Therapeutics
    7.13 Mitobridge
    7.14 Exelixis, Inc.
    7.15 Outpost Medicine
    7.16 Anchor Therapeutics
    7.17 Verva Pharmaceuticals

8 Metabolic Disorders Drugs Manufacturing Cost Analysis
    8.1 Metabolic Disorders Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Metabolic Disorders Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Metabolic Disorders Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Metabolic Disorders Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Metabolic Disorders Drugs Market Forecast (2017-2022)
    12.1 Global Metabolic Disorders Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Metabolic Disorders Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Metabolic Disorders Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Metabolic Disorders Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Metabolic Disorders Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Metabolic Disorders Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Metabolic Disorders Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Metabolic Disorders Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Metabolic Disorders Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Metabolic Disorders Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Metabolic Disorders Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Metabolic Disorders Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Metabolic Disorders Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer